In addition, MDSCs upregulate the expression of Programmed cell death protein ligand 1 (PD-L1), blocking the anti-tumour T cell-mediated activity via an interaction with the programmed cell death protein 1 (PD-1) receptor of these cells [61]. This evidence concerns the gene CD274 and neoplasm.